Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

AVB-500

Aravive (ARAV.Q), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, announced positive initial results today from the Phase 1b portion of its Phase 1b/2 study of…